Vedanta Biosciences
Vedanta Biosciences is advancing first-in-class Live Biotherapeutic Products (LBP) to treat serious gastrointestinal diseases using defined consortia of bacteria.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Vedanta Biosciences is a biotech company focused on developing oral therapies using defined bacterial consortia to treat gastrointestinal diseases, with an initial focus on prevention of recurrent Clostridium difficile infection. The company is conducting clinical trials in recurrent C. difficile infection and has a pipeline of advanced clinical-stage candidates.
History
Vedanta Biosciences is advancing first-in-class Live Biotherapeutic Products (LBP) to treat serious gastrointestinal diseases using defined consortia of bacteria. The company is developing oral therapies using defined bacterial consortia with an initial focus on prevention of recurrent Clostridium difficile infection. It is conducting clinical trials in recurrent C. difficile infection to evaluate the efficacy and safety of potential drug candidates.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/vedanta-biosciences · Editorial policy · How profiles are compiled